产品名称：Human EphA3 Antibody (Ifabotuzumab, Research Use)
产品编号：NBR-0670
针对靶点：EphA3
抗体药商品名：Ifabotuzumab
抗体药描述：Ifabotuzumab (formerly KB004) is a first-in-class therapeutic non-fucosylated IgG1 (human f-allotype) monoclonal antibody being developed by Humanigen (formerly KaloBios Pharmaceuticals) for the treatment of cancer. The drug was licensed from the Ludwig Institute for Cancer Research. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: EphA3
Synonyms: HEK4; TYRO4; ETK1
Target Description: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells.
Ensembl: ENSG00000044524
Uniprot: P29320